| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 67877-614-15 | 67877-614 | HUMAN PRESCRIPTION DRUG | Tizanidine | Tizanidine | TABLET | ORAL | 20190127 | N/A | ANDA | ANDA211798 | Ascend Laboratories, LLC | TIZANIDINE HYDROCHLORIDE | 4 mg/1 | 150 TABLET in 1 BOTTLE (67877-614-15) |
| 67877-614-05 | 67877-614 | HUMAN PRESCRIPTION DRUG | Tizanidine | Tizanidine | TABLET | ORAL | 20190127 | N/A | ANDA | ANDA211798 | Ascend Laboratories, LLC | TIZANIDINE HYDROCHLORIDE | 4 mg/1 | 500 TABLET in 1 BOTTLE (67877-614-05) |
| 67877-613-15 | 67877-613 | HUMAN PRESCRIPTION DRUG | Tizanidine | Tizanidine | TABLET | ORAL | 20190127 | N/A | ANDA | ANDA211798 | Ascend Laboratories, LLC | TIZANIDINE HYDROCHLORIDE | 2 mg/1 | 150 TABLET in 1 BOTTLE (67877-613-15) |
| 67877-613-05 | 67877-613 | HUMAN PRESCRIPTION DRUG | Tizanidine | Tizanidine | TABLET | ORAL | 20190127 | N/A | ANDA | ANDA211798 | Ascend Laboratories, LLC | TIZANIDINE HYDROCHLORIDE | 2 mg/1 | 500 TABLET in 1 BOTTLE (67877-613-05) |